HeyJaredAnn Rheum Dis
- Indexed articles, last 90 days
- 5
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Sep 1, 2026
Latest articles
Steroid Injections in Early RA Tied to Lower Long-Term Use (opens the original)
Read excerpt
Patients with early rheumatoid arthritis (RA) who used parenteral glucocorticoid (GC) injections (intramuscular or intra-articular) were less likely to remain on GCs after 1 year than those who used oral GCs, while disease control did not differ. "[The] findings highlight the potential role of parenteral GC as an effective and practical bridging strategy in early RA management," the authors of the study wrote. The study was led by Andreu Fernández-Codina, Western University in London, Ontario, C
Deep Learning System Detects Lesions in Sacroiliac Joints (opens the original)
Read excerpt
A fully automated deep learning system detected active inflammatory and structural lesions in MRI scans of sacroiliac joints (SIJs) in patients with axial spondyloarthritis (axSpA), with performance comparable to expert readers and higher accuracy for structural lesions, especially ankylosis. "[T]his study demonstrates that a fully automated MRI pipeline can reliably detect both active and structural SIJ lesions in axSpA in a cross-sectional setting with performance comparable with expert interr
Memantine May Help Improve Cognition in Patients With SLE (opens the original)
Read excerpt
Patients with systemic lupus erythematosus (SLE) and measurable cognitive deficits who received memantine for 12 weeks showed greater improvements in objective cognitive performance, especially immediate memory, than those who received placebo. "[The study] provides a proof of concept that memantine may be an effective therapeutic for cognitive manifestations of NPSLE [neuropsychiatric SLE]. Larger trials are needed to confirm these results," the authors of the study wrote. The study was led by
Three-Step Triage May Speed Assessment of Rheumatic Diseases (opens the original)
Read excerpt
A brief consultation with a rheumatologist within a three-step triage system correctly identified about two thirds of patients with inflammatory rheumatic and musculoskeletal disease (iRMD) and missed about one third. Patients with iRMD reached final assessment faster than those without the condition. "The triage approach evaluated in this study showed a fair performance, demonstrating that assessment of patients with iRMD can be prioritised within rheumatology referrals. Integration of ML [mach
Rilzabrutinib May Be Promising in IgG4-Related Disease (opens the original)
Read excerpt
In patients with immunoglobulin (Ig)G4-related disease, treatment with rilzabrutinib — an oral, reversible Bruton tyrosine kinase inhibitor (BTKi) — resulted in around 70% of patients remaining flare-free and off glucocorticoids (GCs) or immunosuppressants for up to 52 weeks. Reductions in disease activity were observed in those with prior rituximab exposure and those who were naive to rituximab. "[T]he data from this phase 2 trial suggest that rilzabrutinib treatment resulted in clinically mean
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.